Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Renée D. Galá
CEORenée D. Galá
Employees
2,890
Employees2,890
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,890
Employees2,890

JAZZ Key Statistics

Market cap
15.50B
Market cap15.50B
Price-Earnings ratio
81.53
Price-Earnings ratio81.53
Dividend yield
—
Dividend yield—
Average volume
831.88K
Average volume831.88K
High today
$243.25
High today$243.25
Low today
$235.89
Low today$235.89
Open price
$241.77
Open price$241.77
Volume
490.88K
Volume490.88K
52 Week high
$266.38
52 Week high$266.38
52 Week low
$139.27
52 Week low$139.27

Stock Snapshot

The current Jazz Pharmaceuticals(JAZZ) stock price is $241.55, with a market capitalization of 15.5B. The stock trades at a price-to-earnings (P/E) ratio of 81.53.

As of 2026-11-14, Jazz Pharmaceuticals(JAZZ) stock has fluctuated between $235.89 and $243.25. The current price stands at $241.55, placing the stock +2.4% above today's low and -0.7% off the high.

The Jazz Pharmaceuticals(JAZZ)'s current trading volume is 490.88K, compared to an average daily volume of 831.88K.

During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $139.27 at its lowest and $266.38 at its peak.

During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $139.27 at its lowest and $266.38 at its peak.

JAZZ News

Investing.com 2d
Piper Sandler raises Jazz Pharmaceuticals price target on Ziihera outlook - Investing.com

...

Piper Sandler raises Jazz Pharmaceuticals price target on Ziihera outlook - Investing.com
Simply Wall St 4d
Should Raised Guidance Require Action From Jazz Pharmaceuticals Stock Investors?

Jazz Pharmaceuticals reported third quarter 2026 revenue of US$1,243 million and a net loss of US$483.4 million, while raising full year revenue guidance and an...

Should Raised Guidance Require Action From Jazz Pharmaceuticals Stock Investors?
Zacks 5d
Don't Overlook Jazz International Revenue Trends While Assessing the Stock

Have you evaluated the performance of Jazz Pharmaceuticals' (JAZZ Quick QuoteJAZZ - Free Report) international operations during the quarter that conclud...

Don't Overlook Jazz International Revenue Trends While Assessing the Stock

Analyst ratings

88%

of 24 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.